Skip to content
10-Q

Quarterly Report

NIKA PHARMACEUTICALS, INC NIKA

0001826466-25-000096

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 7, 2025 1.04B sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.04B sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.04B sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.02B sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.02B sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$40.8K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$126.63K
Short Term Debt Q3 2025 · Sep 30, 2025 $284.16K
Short Term Debt Q3 2025 · Dec 31, 2024 $239.16K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $6.29K
Cash And Equivalents Q3 2025 · Dec 31, 2024 $2.08K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$260.54K
Stockholders Equity Q3 2025 · Jun 30, 2025 −$252.56K
Stockholders Equity Q3 2025 · Mar 31, 2025 −$234.18K
Stockholders Equity Q3 2025 · Dec 31, 2024 −$221.23K
Stockholders Equity restated Q3 2025 · Sep 30, 2024 −$200.41K
Stockholders Equity restated Q3 2025 · Jun 30, 2024 −$208.78K
Stockholders Equity Q3 2025 · Mar 31, 2024 −$224.48K
Stockholders Equity Q3 2025 · Dec 31, 2023 −$82.15K
Current Liabilities Q3 2025 · Sep 30, 2025 $284.16K
Current Liabilities Q3 2025 · Dec 31, 2024 $239.16K
Total Liabilities Q3 2025 · Sep 30, 2025 $284.16K
Total Liabilities Q3 2025 · Dec 31, 2024 $239.16K
Current Assets Q3 2025 · Sep 30, 2025 $23.63K
Current Assets Q3 2025 · Dec 31, 2024 $17.93K
Total Assets Q3 2025 · Sep 30, 2025 $23.63K
Total Assets Q3 2025 · Dec 31, 2024 $17.93K
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2024 $0.00
Eps Diluted Q3 2025 · Sep 30, 2024 $0.00
Sga Expense Q3 2025 · Sep 30, 2025 $3.9K
Sga Expense Q3 2025 · Sep 30, 2025 $20K
Sga Expense Q3 2025 · Sep 30, 2024 $6.3K
Sga Expense restated Q3 2025 · Sep 30, 2024 $28.82K
Net Income Q3 2025 · Sep 30, 2025 −$8K
Net Income Q3 2025 · Sep 30, 2025 −$39.31K
Net Income Q3 2025 · Sep 30, 2024 −$8.37K
Net Income restated Q3 2025 · Sep 30, 2024 −$83.34K
Operating Income Q3 2025 · Sep 30, 2025 −$8K
Operating Income Q3 2025 · Sep 30, 2025 −$39.31K
Operating Income Q3 2025 · Sep 30, 2024 −$8.37K
Operating Income restated Q3 2025 · Sep 30, 2024 −$83.34K